CN104740677A - 一种皮肤医用修复敷料及其制备方法 - Google Patents
一种皮肤医用修复敷料及其制备方法 Download PDFInfo
- Publication number
- CN104740677A CN104740677A CN201510196240.8A CN201510196240A CN104740677A CN 104740677 A CN104740677 A CN 104740677A CN 201510196240 A CN201510196240 A CN 201510196240A CN 104740677 A CN104740677 A CN 104740677A
- Authority
- CN
- China
- Prior art keywords
- skin
- allantoin
- vitamin
- dressing
- licorice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 64
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 63
- 102000008186 Collagen Human genes 0.000 claims abstract description 62
- 108010035532 Collagen Proteins 0.000 claims abstract description 62
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 62
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 32
- 229960000458 allantoin Drugs 0.000 claims abstract description 32
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 31
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000011709 vitamin E Substances 0.000 claims abstract description 31
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 31
- 229940046009 vitamin E Drugs 0.000 claims abstract description 31
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 30
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 30
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 30
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 30
- 229940010454 licorice Drugs 0.000 claims abstract description 30
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 29
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 29
- 241000202807 Glycyrrhiza Species 0.000 claims description 29
- 230000010261 cell growth Effects 0.000 claims description 29
- 229940041616 menthol Drugs 0.000 claims description 29
- 239000011550 stock solution Substances 0.000 claims description 29
- 239000008367 deionised water Substances 0.000 claims description 28
- 229910021641 deionized water Inorganic materials 0.000 claims description 28
- 239000003102 growth factor Substances 0.000 claims description 28
- 239000002994 raw material Substances 0.000 claims description 20
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims 1
- 229920001436 collagen Polymers 0.000 abstract description 16
- 230000003020 moisturizing effect Effects 0.000 abstract description 9
- 230000008439 repair process Effects 0.000 abstract description 7
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 230000009759 skin aging Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000011994 cellular protein metabolic process Effects 0.000 abstract description 2
- 230000008591 skin barrier function Effects 0.000 abstract description 2
- 102000018386 EGF Family of Proteins Human genes 0.000 abstract 1
- 108010066486 EGF Family of Proteins Proteins 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 230000001934 delay Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000037394 skin elasticity Effects 0.000 abstract 1
- 230000037339 smooth wrinkles Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 86
- 230000000694 effects Effects 0.000 description 12
- 210000004927 skin cell Anatomy 0.000 description 8
- 230000037303 wrinkles Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 206010048222 Xerosis Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000004952 protein activity Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010006242 Breast enlargement Diseases 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 102000001690 Factor VIII Human genes 0.000 description 1
- 108010054218 Factor VIII Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 241000863032 Trieres Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510196240.8A CN104740677B (zh) | 2015-04-23 | 2015-04-23 | 一种皮肤医用修复敷料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510196240.8A CN104740677B (zh) | 2015-04-23 | 2015-04-23 | 一种皮肤医用修复敷料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104740677A true CN104740677A (zh) | 2015-07-01 |
CN104740677B CN104740677B (zh) | 2017-06-06 |
Family
ID=53581286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510196240.8A Active CN104740677B (zh) | 2015-04-23 | 2015-04-23 | 一种皮肤医用修复敷料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104740677B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105169374A (zh) * | 2015-10-23 | 2015-12-23 | 东莞市达庆医疗器械有限公司 | 一种重组人源胶原蛋白凝胶及其制备方法 |
CN108096138A (zh) * | 2017-12-21 | 2018-06-01 | 广东科玮生物技术股份有限公司 | 一种抗衰老皮肤修复液及其制备方法 |
CN108187026A (zh) * | 2018-03-16 | 2018-06-22 | 南京财经大学 | 一种能够促进伤口愈合的产品 |
CN111437433A (zh) * | 2020-05-08 | 2020-07-24 | 海南卓瑞生物医药有限公司 | 皮肤护理敷料制备方法及皮肤护理敷料 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0267015A2 (en) * | 1986-11-05 | 1988-05-11 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
US20080280323A1 (en) * | 2004-11-03 | 2008-11-13 | Sun Lee | Method for Producing Epidermal Growth Factor Using Fusion Proteins Comprising Fas-1 Domain |
CN101316618A (zh) * | 2005-11-14 | 2008-12-03 | 株式会社大熊 | 包含表皮生长因子的用于愈合伤口的缓释膜剂 |
CN102895164A (zh) * | 2012-09-25 | 2013-01-30 | 石磊 | 一种凝水面膜及其制备方法 |
CN104027836A (zh) * | 2014-06-24 | 2014-09-10 | 南京仁天生物科技有限公司 | 一种与皮肤协同作用的敷料及其制备和应用 |
CN104288828A (zh) * | 2014-10-29 | 2015-01-21 | 广西信业生物技术有限公司 | 一种医用生物抑瘢除皱敷料及其制备方法 |
-
2015
- 2015-04-23 CN CN201510196240.8A patent/CN104740677B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0267015A2 (en) * | 1986-11-05 | 1988-05-11 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
US20080280323A1 (en) * | 2004-11-03 | 2008-11-13 | Sun Lee | Method for Producing Epidermal Growth Factor Using Fusion Proteins Comprising Fas-1 Domain |
CN101316618A (zh) * | 2005-11-14 | 2008-12-03 | 株式会社大熊 | 包含表皮生长因子的用于愈合伤口的缓释膜剂 |
CN102895164A (zh) * | 2012-09-25 | 2013-01-30 | 石磊 | 一种凝水面膜及其制备方法 |
CN104027836A (zh) * | 2014-06-24 | 2014-09-10 | 南京仁天生物科技有限公司 | 一种与皮肤协同作用的敷料及其制备和应用 |
CN104288828A (zh) * | 2014-10-29 | 2015-01-21 | 广西信业生物技术有限公司 | 一种医用生物抑瘢除皱敷料及其制备方法 |
Non-Patent Citations (1)
Title |
---|
许伟石等: "《烧伤创面修复》", 31 October 2013, 湖北科学技术出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105169374A (zh) * | 2015-10-23 | 2015-12-23 | 东莞市达庆医疗器械有限公司 | 一种重组人源胶原蛋白凝胶及其制备方法 |
CN108096138A (zh) * | 2017-12-21 | 2018-06-01 | 广东科玮生物技术股份有限公司 | 一种抗衰老皮肤修复液及其制备方法 |
CN108187026A (zh) * | 2018-03-16 | 2018-06-22 | 南京财经大学 | 一种能够促进伤口愈合的产品 |
CN111437433A (zh) * | 2020-05-08 | 2020-07-24 | 海南卓瑞生物医药有限公司 | 皮肤护理敷料制备方法及皮肤护理敷料 |
Also Published As
Publication number | Publication date |
---|---|
CN104740677B (zh) | 2017-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10869948B2 (en) | Composition of collagen peptide and elastin peptide, method of producing the same and use thereof | |
CN105616184B (zh) | 一种透明质酸多肽键合物面膜及其制备方法 | |
CN107496325A (zh) | 含牡丹精油、青瓜提取液和蜗牛原液的面膜及其制备方法 | |
CN110448509A (zh) | 一种具有舒敏修复功效的多肽精华液及其制备方法 | |
CN104586695A (zh) | 含仙人掌精华具有深度补水保湿功效的护肤品 | |
CN104740677A (zh) | 一种皮肤医用修复敷料及其制备方法 | |
CN105193673B (zh) | 一种清痘修复液及其制备方法 | |
CN110833516B (zh) | 一种具有补水保湿作用的多肽组合物 | |
CN104644523A (zh) | 一种医用生物除皱抑斑敷料及其制备方法 | |
CN109998986A (zh) | 一种二裂酵母冻干粉制剂及其制备方法 | |
CN110559247A (zh) | 一种多肽植物天然面膜及应用 | |
CN104490713A (zh) | 一种具有排浊紧致和抗皱活化肌肤功能的超软活泉护肤品 | |
CN108498357A (zh) | 一种类人胶原蛋白面膜液及其制作方法 | |
JP2008100943A (ja) | インスリン様成長因子−1分泌促進作用を有する皮膚外用剤 | |
CN104546591A (zh) | 一种植物精油面膜及其制备方法 | |
CN103520017A (zh) | 一种除皱抗衰、活化肌肤、修复美白的组合物 | |
CN106309151A (zh) | 蛋白维他命粉红面膜液及生产方法 | |
CN104922008A (zh) | 一种除色斑精华素 | |
CN107308028A (zh) | 透皮给药精华液 | |
WO2007046353A1 (ja) | 線維芽細胞賦活剤および線維芽細胞賦活方法、コラーゲン合成促進剤およびコラーゲン合成促進方法、ならびに皮膚老化防止剤および皮膚老化防止方法 | |
CN110496069A (zh) | 一种小分子聚肽原液及其制备方法 | |
US20160243021A1 (en) | Collagen-Boosting Compositions And Methods | |
CN106420399A (zh) | 一套激光美容术护理剂及其制备与使用方法 | |
CN108721136A (zh) | 修护凝胶及其制备方法和应用 | |
CN109288745A (zh) | 一种嫩肤养护化妆品组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 537300, Guigang County, the Guangxi Zhuang Autonomous Region, Linjiang Industrial Park, third feeder roads and access to the South Road junction, Guangxi grand Biological Technology Co., Ltd. Applicant after: GUANGXI DAQING BIOTECHNOLOGY Co.,Ltd. Address before: 537300, Guigang County, the Guangxi Zhuang Autonomous Region, Linjiang Industrial Park, third feeder roads and access to the South Road junction, Guangxi grand Biological Technology Co., Ltd. Applicant before: GUANGXI DAQING BIOLOGICAL SCIENCE & TECHNOLOGY CO.,LTD. |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 537000 Pingnan County Industrial Park, Guigang City, the Guangxi Zhuang Autonomous Region Patentee after: GUANGXI DAQING BIOLOGICAL SCIENCE & TECHNOLOGY CO.,LTD. Address before: 537300 the Guangxi Zhuang Autonomous Region, Guigang City, Pingnan County Linjiang Industrial Park third branch road and the junction of the South Road, Guangxi Daqing Biotechnology Co., Ltd. Patentee before: GUANGXI DAQING BIOTECHNOLOGY Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150701 Assignee: GUANGXI XINYE BIOLOGICAL TECHNOLOGY Co.,Ltd. Assignor: GUANGXI DAQING BIOLOGICAL SCIENCE & TECHNOLOGY CO.,LTD. Contract record no.: X2023980043753 Denomination of invention: A medical skin repair dressing and its preparation method Granted publication date: 20170606 License type: Common License Record date: 20231019 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A medical skin repair dressing and its preparation method Effective date of registration: 20231030 Granted publication date: 20170606 Pledgee: Bank of China Limited Pingnan Branch Pledgor: GUANGXI DAQING BIOLOGICAL SCIENCE & TECHNOLOGY CO.,LTD. Registration number: Y2023980063362 |